| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA28486
Max Phase: Preclinical
Molecular Formula: C20H36O5
Molecular Weight: 356.50
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCCCCCCCCCCCCCOC(=O)[C@@H]1CC(=O)O[C@H]1CO
Standard InChI: InChI=1S/C20H36O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-24-20(23)17-15-19(22)25-18(17)16-21/h17-18,21H,2-16H2,1H3/t17-,18+/m1/s1
Standard InChI Key: YHAJQFWQXDADHR-MSOLQXFVSA-N
Associated Targets(non-human)
Prkca Protein kinase C (PKC) (359 Activities)
Prkca Protein kinase C alpha (23 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 356.50 | Molecular Weight (Monoisotopic): 356.2563 | AlogP: 4.15 | #Rotatable Bonds: 15 |
| Polar Surface Area: 72.83 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.81 | CX LogD: 4.81 |
| Aromatic Rings: 0 | Heavy Atoms: 25 | QED Weighted: 0.35 | Np Likeness Score: 0.83 |
References
| 1. Lee J, Sharma R, Teng K, Lewin NE, Blumberg PM, Marquez VE. (1994) Conformationally constrained analogues of dag .8. Changes in PK-C binding affinity produced by isosteric groups of the 3-O-acyl function in 2-deoxy-L-ribonolactones, 4 (11): [10.1016/S0960-894X(01)80364-4] |
Source
Source(1):